80 related articles for article (PubMed ID: 20164693)
21. [Therapeutic strategy].
Emery E; Kehrli P; Nataf F; Seigneuret E
Neurochirurgie; 1999 Dec; 45(5):398-400. PubMed ID: 10717589
[No Abstract] [Full Text] [Related]
22. [A successful combination therapy with resection and infusion chemotherapy for a patient with metastases from cancer of unknown origin].
Nakagawa Y; Todoroki T; Koike N; Kawamoto T
Gan To Kagaku Ryoho; 2003 Mar; 30(3):423-6. PubMed ID: 12669405
[TBL] [Abstract][Full Text] [Related]
23. Unknown primary tumors: is there a future therapeutic role for immune checkpoint inhibitors?
Kourie HR; Awada G; Awada AH
Future Oncol; 2016 Feb; 12(4):429-31. PubMed ID: 26776661
[No Abstract] [Full Text] [Related]
24. Signet-ring cell carcinoma of unknown primary location. Metastatic to lower back musculature - remission following FU/FA chemotherapy.
Heidemann J; Gockel HR; Winde G; Herbst H; Domschke W; Lügering N
Z Gastroenterol; 2002 Jan; 40(1):33-6. PubMed ID: 11803498
[TBL] [Abstract][Full Text] [Related]
25. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
[TBL] [Abstract][Full Text] [Related]
26. [Surprisingly positive effect of palliative CAP chemotherapy of bone-disseminated, undifferentiated carcinoma of unknown primary origin in patient with low performance status according to WHO].
Swiatoniowski G; Bruzewicz S; Suder E; Warszylewicz-Szymanek M; Kłaniewski T; Prudlak E; Molenda W; Setta M
Przegl Lek; 2006; 63(3):166-8. PubMed ID: 16969902
[TBL] [Abstract][Full Text] [Related]
27. Management of peritoneal carcinomatosis of unknown primary tumor site.
Muggia FM; Baranda J
Semin Oncol; 1993 Jun; 20(3):268-72. PubMed ID: 8503022
[No Abstract] [Full Text] [Related]
28. [Toward an evaluation of patients with cancer of unknown origin based on the histological diagnosis. A proposed algorithm].
Mayordomo Cámara JI; Guerra Vales JM
Med Clin (Barc); 1994 Mar; 102(11):423-6. PubMed ID: 8183000
[No Abstract] [Full Text] [Related]
29. 5-fluorouracil and leucovorin as second-line chemotherapy in carcinomas of unknown primary site.
Culine S; Ychou M; Fabbro M; Romieu G; Cupissol D
Anticancer Res; 2001; 21(2B):1455-7. PubMed ID: 11396231
[TBL] [Abstract][Full Text] [Related]
30. Skin metastases from unknown origin: role of immunohistochemistry in the evaluation of cutaneous metastases of carcinoma of unknown origin.
Azoulay S; Adem C; Pelletier FL; Barete S; Francès C; Capron F
J Cutan Pathol; 2005 Sep; 32(8):561-6. PubMed ID: 16115055
[TBL] [Abstract][Full Text] [Related]
31. [Malignant cervical adenopathies of unknown origin].
Martínez Martínez MJ; Ayala Martínez L; Ruiz Gómez JM
Acta Otorrinolaringol Esp; 1997; 48(5):383-5. PubMed ID: 9376159
[TBL] [Abstract][Full Text] [Related]
32. From gene testing to the bedside: workshop focuses on future strategies.
Goozner M
J Natl Cancer Inst; 2011 Aug; 103(15):1150-1. PubMed ID: 21768535
[No Abstract] [Full Text] [Related]
33. Temporary worsening of parkinsonism in a patient with Parkinson's disease after treatment with paclitaxel for a metastatic grade IV adenocarcinoma.
Bower JH; Muenter MD
Mov Disord; 1995 Sep; 10(5):681-2. PubMed ID: 8552128
[No Abstract] [Full Text] [Related]
34. Making strides to treat the unknown: carcinoma of unknown primary.
Reynolds T
J Natl Cancer Inst; 1998 Feb; 90(4):268-9. PubMed ID: 9486809
[No Abstract] [Full Text] [Related]
35. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.
Sulkes A; Uziely B; Isacson R; Brufman G; Biran S
Isr J Med Sci; 1988; 24(9-10):604-10. PubMed ID: 3204009
[TBL] [Abstract][Full Text] [Related]
36. Combination chemotherapy in the treatment of adenocarcinoma of unknown primary origin.
Walach N; Horn Y
Cancer Treat Rep; 1987 Jun; 71(6):605-7. PubMed ID: 3581098
[TBL] [Abstract][Full Text] [Related]
37. Facilitating patient-centered cancer research and a new era of drug discovery.
Niederhuber JE
Oncologist; 2009 Apr; 14(4):311-2. PubMed ID: 19365096
[No Abstract] [Full Text] [Related]
38. [A case of adenosquamous carcinoma with unknown origin and with superior vena cava syndrome as the first symptom].
Oka M; Kusano M; Miyasaka T; Suganuma Y; Shimojo J; Aoki R; Hoshino M; Ashitaka T; Hosaka K; Fukushima Y
Kekkaku; 1992 Jun; 67(6):457-62. PubMed ID: 1625406
[TBL] [Abstract][Full Text] [Related]
39. Cancer clinical trials: development and implementation.
Vail DM
Vet Clin North Am Small Anim Pract; 2007 Nov; 37(6):1033-57; v. PubMed ID: 17950881
[TBL] [Abstract][Full Text] [Related]
40. The management of patients with adenocarcinoma and poorly differentiated carcinoma of unknown primary site.
Greco FA; Hainsworth JD
Semin Oncol; 1989 Aug; 16(4 Suppl 6):116-22. PubMed ID: 2669133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
